AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 40 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 40 | -27.3% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 55 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 55 | -26.7% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 75 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |